NOD2 (or RIPK2) deficiency results in increased susceptibility to tumor formation in AOM/DSS mouse model of colon cancer. Absence of NOD2 (or RIPK2) promotes pro‐inflammatory microenvironment in the intestines leading to enhanced epithelial dysplasia following chemically induced injury. Here, RIPK2 is linked to neoplasm.